Desk›Healthcare› Acutaas Chemicals Ltd
Acutaas Chemicals Ltd
BSE 543349 · NSE ACUTAAS · ISIN INE00FF01025 · Group A · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹3,282.10
-1.51%
BSE close, 28 August 2026
₹26,870.92 cr
8.2 cr shares · Mid cap
₹16,908.88 cr
as published
67.6× · 22.33×
EPS ₹48.54 · BV ₹146.98
1,323.79 / 366.18
₹ cr, as filed
19
7 selected · 37%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -12.1% |
|---|---|
| Against 52-week low | +154.4% |
| Day change | -1.51% |
| Size band | Mid cap |
| Index membership | NIFTY 500 |
Valuation as published by BSE
| Earnings per share | ₹48.54 |
|---|---|
| Price / earnings | 67.62× |
| Price / book | 22.33× |
| Book value — derived, price ÷ P/B | ₹146.98 |
| Return on equity | 33.03% |
| Operating margin | 35.41% |
| Net margin | 23.54% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 33.02%
- ROE as published
- 33.03%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 322.41 | 75.90 | 9.27 | 35.41% | 23.54% |
| Mar-26 · Q | 421.77 | 137.07 | 16.74 | 46.41% | 32.50% |
| FY25-26 | 1,323.79 | 366.18 | 44.73 | 39.95% | 27.66% |
Quarter on quarter
- Revenue, quarter on quarter
- -23.6%
- Net profit, quarter on quarter
- -44.6%
- Operating margin, quarter on quarter
- -1,100 bps
Disclosure profile 19 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Press Release | 2 |
| Acquisition | 1 |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| Results | 1 |
| Selected sub-total | 7 |
| Procedural | |
| General | 4 |
| Analyst / Investor Meet | 2 |
| Newspaper Publication | 2 |
| AGM / EGM | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Trading Window | 1 |
| Procedural sub-total | 12 |
| Total | 19 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
19 filings · 7 selected · busiest 2026-07-24
Filing rhythm · the twelve most recent
2026-07-282026-10-06
SelectedProcedural
Filings
19 in the window · 5 earlier on record
-
6 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026 is attached.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
24 September 2026 ·
Acquisition
Board of Directors have approved the acquisition of equity shares of step down subsidiary company as per details enclosed.
Company Update / Acquisition View filing →
-
24 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Disclosure of events of the 19th Annual General Meeting held on Thursday, September 24, 2026 is attached.
AGM/EGM / AGM View filing →
-
22 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of Investor Conference/Meet as per details attached.
Company Update / Analyst / Investor Meet View filing →
-
22 September 2026 ·
Closure of Trading Window
Intimation of Closure of Trading Window is attached.
Insider Trading / SAST / Closure of Trading Window View filing →
-
10 September 2026 ·
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Grant Of Patent
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 is attached.
Company Update / General View filing →
-
4 September 2026 ·
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Inauguration Of New Pilot Plant
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 in respect of inauguration of Pilot Plant today at Unit-1 Sachin is enclosed.
Company Update / General View filing →
-
31 August 2026 ·
Newspaper Publication
Newspaper publication for dispatch of notice of 19th AGM along with Annual Report for the FY 2025-26 is enclosed.
Company Update / Newspaper Publication View filing →
-
28 August 2026 ·
Press Release / Media Release
Press Release titled "Acutaas Chemicals' step down subsidiary Indichem inaugurates Semiconductor Materials Plant at Gongju , The Republic of Korea", is attached.
Company Update / Press Release / Media Release View filing →
-
24 August 2026 ·
Newspaper Publication
Newspaper Publication in respect of 19th AGM of the company scheduled to be held on Thursday, September 24, 2026 is attached
Company Update / Newspaper Publication View filing →
-
18 August 2026 ·
Intimation Under Regulation 30 Of SEBI LODR Regulations, 2015 - Approval Under ECMS Scheme
We wish to inform you that, Ministry of Electronics and Information Technology has accorded its approval for the incentive package under the ECMS scheme as per the details attached
Company Update / General View filing →
-
28 July 2026 ·
Earnings Call Transcript
Transcript of Earnings Call Q1 FY27 financial results held on July 24, 2026 is enclosed.
Company Update / Earnings Call Transcript View filing →
-
24 July 2026 ·
Earnings Call Recording Pursuant To SEBI (LODR) Regulations, 2015
Recording of the Earnings Call held on July 24, 2026 is enclosed
Company Update / General View filing →
-
24 July 2026 ·
Investor Presentation
Investor Presentation on financial results for the first quarter ended June 30, 2026 is attached.
Company Update / Investor Presentation View filing →
-
24 July 2026 ·
Press Release / Media Release
Press Release discussing the financial results of first quarter ended as on June 30, 2026 is attached.
Company Update / Press Release / Media Release View filing →
-
24 July 2026 ·
Unaudited Standalone And Consolidated Financial Results For First Quarter Ended June 30, 2026
Unaudited Financial Results for the quarter ended June 30, 2026 is enclosed.
Result / Financial Results View filing →
-
24 July 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On July 24, 2026
The Board of Directors of the Company at their meeting held on Friday, July 24, 2026, inter alia, considered & approved Unaudited Standalone & Consolidated Financial Results of the Company ....
Board Meeting / Outcome of Board Meeting View filing →
-
20 July 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Earnings conference call scheduled on July 24, 2026 at 04.00 P.M. (IST)
Company Update / Analyst / Investor Meet View filing →
-
20 July 2026 ·
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended June 30, 2026 Scheduled On July 24, 2026.
Acutaas Chemicals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 ,inter alia, to consider and approve Unaudited standalone & consolidated ....
Board Meeting / Board Meeting View filing →
RSS feed for Acutaas Chemicals Ltd · the 50 most recent filings